|
UX7 Series Endoscope Camera System (4K, NIR Fluorescence & 3D)
[2 sentences max: connect the product to a broader system, market behavior, or supply chain reality.]
Minimally invasive surgery places extraordinary demands on imaging—resolution, depth perception, and the ability to visualize tissue function, not just anatomy. The operating room is, in effect, a high-stakes optical environment where the margin between a clear margin and a missed lesion can be measured in microns. The UX7 Series Endoscope Camera System, developed through full-chain independent R&D, represents a serious Chinese entry into this demanding landscape, integrating true 4K, near-infrared (NIR) fluorescence, and real-time 3D visualization into a single platform.
The system’s core is a dual-chip true 4K sensor architecture that delivers high dynamic range and homogeneous brightness—critical for avoiding glare on wet, reflective tissue. This is paired with an intelligent image pipeline that includes autofocus, automatic scene recognition, and anti-fog optimization via active chip-on-tip heating. These features directly address the physical realities of endoscopic surgery: fogged lenses, shifting light levels, and the need for constant manual refocusing.
The NIR fluorescence imaging goes beyond mere structural visualization. Surgeons can inject a fluorescent dye like indocyanine green (ICG) and observe real-time perfusion, helping to assess blood supply to a bowel anastomosis or identify sentinel lymph nodes. The system’s fluorescence stabilization algorithm ensures that the signal remains consistent, reducing cognitive load during complex dissections. This moves the platform from a simple camera to a diagnostic tool in its own right.
The 3D visualization, meanwhile, reintroduces depth perception that is lost in traditional 2D laparoscopy. Surgeons operating on intricate structures—the biliary tree, the prostate, or the thoracic cavity—gain spatial cues that can reduce operative time and the risk of inadvertent injury. The system’s modular design, with endoscope diameters from 3 mm to 10 mm and viewing angles of 0° and 30°, makes it adaptable across general surgery, urology, gynecology, and thoracic procedures.
What is significant here is not just the feature set, but the supply chain posture. The UX7, with its full-chain domestic R&D, signals that the Chinese medical imaging ecosystem has matured to the point where it can compete with established players from Germany, Japan, and the United States on core optical and sensor engineering. The lightweight camera heads—190 grams for white light, 240 grams for fluorescence—suggest a design optimized for surgeon ergonomics and for the assembly tolerances that a domestic supply chain can now achieve.
For hospital procurement departments, the UX7 represents a platform that consolidates three separate modalities—4K white-light imaging, NIR fluorescence, and 3D—into a single capital expenditure. The PACS compatibility and dual-channel recording capability mean that it integrates into existing digital operating room workflows without requiring a wholesale infrastructure replacement. This reduces both upfront cost and long-term complexity.
The UX7 Series does not attempt to out-innovate its rivals with exotic technology. Instead, it competes on integration, domestic control of critical components, and the ability to deliver a reliable all-in-one system at a price point that reflects local manufacturing advantages. That is a formula that, in medical devices, often matters more than raw specification sheets.
Why it matters:
The UX7 is a bellwether for China’s ability to penetrate the high-margin surgical imaging market. For buyers, it offers a competitive alternative to established imports, with the logistical benefit of domestic service and supply chains. For competitors, it signals that the technological gap on core sensor and optical integration is narrowing.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|